Parameters assessing neurological status in malignant glioma patients: prognostic value for survival and relapse-free time

References

• Kleihues P, Ohgaki H. Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro-oncol 1999; 1: 44–51
   PubMedGoogle Scholar
• Lacroix M, Abi-Said D, Fourney D R, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection and survival. J Neurosurg 2001; 95: 190–198
   PubMed Web of Science ®Google Scholar
• Shapiro W R, Green S B, Burger P C, et al. Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. J Neurosurg 1989; 71: 1–9
   PubMed Web of Science ®Google Scholar
• Scott J N, Rewcastle N B, Brasher P MA, et al. Which glioblastoma multiforme patient will become a long-term survivor? A population based study. Ann Neurol 1999; 46: 183–188
   PubMed Web of Science ®Google Scholar
• Chandler K L, Prados M D, Malec M, Wilson C B. Long-term survival in patients with glioblastoma multiforme. Neurosurgery 1993; 32: 716–720
   PubMed Web of Science ®Google Scholar
• Black P M, Alexander E, 3rd, Martin C, et al. Craniotomy for tumor treatment in an intraoperative magnetic resonance imaging unit. Neurosurgery 1999; 45: 423–431
   PubMed Web of Science ®Google Scholar
• Hammoud M A, Ligon B L, elSouki R, et al. Use of intraoperative ultrasound for localizing tumors and determining the extent of resection: a comparative study with magnetic resonance imaging. J Neurosurg 1996; 84: 737–741
   PubMed Web of Science ®Google Scholar
• Hentschel S J, Sawaya R. Optimizing outcomes with maximal surgical resection of malignant gliomas. Cancer Control 2003; 10: 109–114
   PubMedGoogle Scholar
• Chan T A, Weingart J D, Parisi M, et al. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy. Int J Radiat Oncol Biol Phys 2005; 62: 1133–1139
   PubMed Web of Science ®Google Scholar
• Westphal M, Hilt D C, Bortey E, et al. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro-oncol 2003; 5(2)79–88
   PubMed Web of Science ®Google Scholar
• Brell M, Ibanez J, Caral L, Ferrer E. Factors influencing surgical complications of intra-axial brain tumours. Acta Neurochir (Wien) 2000; 142: 739–750
   PubMed Web of Science ®Google Scholar
• Sawaya R, Hammoud M, Schoppa D, et al. Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 1998; 42: 1044–1055
   PubMed Web of Science ®Google Scholar
• Central Brain Tumor Registry of the United States. Statistical report: primary brain tumors in the United States 1998–2002, Available at: http://www.cbtrus.org/reports//2005–2006/2006report.pdf (accessed 18 May 2007)
   Google Scholar
• Hess K R. Extent of resection as a prognostic variable in the treatment of gliomas. J Neurooncol 1999; 42: 227–231
   PubMed Web of Science ®Google Scholar
• Metcalfe S E, Grant R. Biopsy versus resection for malignant glioma. Cochrane database Syst Rev, 3: CD002034, 2001
   Google Scholar
• Kaplan E L, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481
   Web of Science ®Google Scholar
• Stupp R, Dietrich P Y, Ostermann Kraljevic S, et al. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 2002; 20: 1375–1382
   PubMed Web of Science ®Google Scholar
• Walker M D, Green S B, Byar D P, et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 1980; 303: 1323–1329
   PubMed Web of Science ®Google Scholar
• Giese A, Bjerkvig R, Berens M E, Westphal M. Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 2003; 21: 1624–1636
   PubMed Web of Science ®Google Scholar
• Kelly P J, Daumas-Duport C, Kispert D B, et al. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 1987; 66: 865–874
   PubMed Web of Science ®Google Scholar
• Ammirati M, Vick N, Liao Y L, Ciric I, Mikhael M. Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery 1987; 21: 201–206
   PubMed Web of Science ®Google Scholar
• Fadul C, Wood J, Thaler H, et al. Morbidity and mortality of craniotomy for excision of supratentorial gliomas. Neurol 1988; 38: 1374–1379
   PubMed Web of Science ®Google Scholar
• Albert F K, Forsting M, Sartor K, Adams H P, Kunze S. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 1994; 34: 45–60
   PubMed Web of Science ®Google Scholar
• Ciric I, Ammirati M, Vick N, Mikhael M. Supratentorial gliomas: surgical considerations and immediate postoperative results. Gross total resection versus partial resection. Neurosurgery 1987; 21: 21–26
   PubMed Web of Science ®Google Scholar
• Nitta T, Sato K. Prognostic implications of the extent of tumor resection in patients with intracranial malignant gliomas. Cancer 1995; 75: 2727–2731
   PubMedGoogle Scholar
• Salcman M. The value of cytoreductive surgery. Clin Neurosurg 1994; 41: 464–488
   PubMedGoogle Scholar
• Kelly P J, Kall B A, Goerss S J. Results of computed tomography-based computer-assisted stereotactic resection of metastatic intracranial tumors. Neurosurgery 1988; 22: 7–17
   PubMed Web of Science ®Google Scholar
• Vives K P, Piepmeier J M. Complications and expected outcome of glioma surgery. J Neurooncol 1999; 42: 289–302
   PubMedGoogle Scholar
• Kreth F W, Warnke P C, Ostertag C B. The limited value of cytoreductive surgery in elderly patients with malignant glioma. Neurosurgery 1994; 35: 144
   Google Scholar
• Latif A Z, Signorini D, Gregor A, et al. Application of the MRC brain tumour prognostic index to patients with malignant glioma not managed in randomised control trial. J Neurol Neurosurg Psychiatry 1998; 64: 747–750
   PubMed Web of Science ®Google Scholar